CEPHALON, INC. $375,000,000 Zero Coupon Convertible Subordinated Notes due June 15, 2033, First Putable June 15, 2008 $375,000,000 Zero Coupon Convertible Subordinated Notes due June 15, 2033, First Putable June 15, 2010Registration Rights Agreement • August 14th, 2003 • Cephalon Inc • Pharmaceutical preparations • New York
Cephalon, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Credit Suisse First Boston LLC (the “Lead Purchaser”), CIBC World Markets Corp., J.P. Morgan Securities Inc., Morgan Stanley & Co. Incorporated, SG Cowen Securities Corporation, ABN AMRO Rothschild LLC, Citigroup Global Markets Inc. and Lehman Brothers Inc. (collectively, the “Initial Purchasers”), upon the terms set forth in a purchase agreement dated as of June 6, 2003 (the “Purchase Agreement”), $300,000,000 aggregate principal amount (plus an additional $75,000,000 principal amount pursuant to an option granted thereunder) of its Zero Coupon Convertible Subordinated Notes due June 15, 2033, First Putable June 15, 2008, and $300,000,000 aggregate principal amount (plus an additional $75,000,000 principal amount pursuant to an option granted thereunder) of its Zero Coupon Convertible Subordinated Notes due June 15, 2033, First Putable June 15, 2010 (together, the “Initial Securities”). The Initial S
March 31, 2003 Martyn D. GreenacreCephalon Inc • August 14th, 2003 • Pharmaceutical preparations
